Recent Analyst Forecasts and Stock Ratings
Neurocrine Biosciences, Inc. FAQ's
Neurocrine Biosciences, Inc. has been rated by research analysts at Morgan Stanley, UBS, BMO Capital, Oppenheimer, Raymond James, Barclays in the past 90 days.
Neurocrine Biosciences, Inc. has been rated by research analysts at Morgan Stanley, UBS, BMO Capital, Oppenheimer, Raymond James, Barclays in the past 90 days.